BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5328125)

  • 1. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1966 May; 15(3):281-6. PubMed ID: 5328125
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the antimalarial effects of cycloguanil pamoate (CI-501) in man.
    Powell RD; DeGowin RL; Eppes RB
    Am J Trop Med Hyg; 1965 Nov; 14(6):913-21. PubMed ID: 5320454
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasmodium resistance to antimalarials].
    Cailhol J; Consigny PH
    Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant malaria.
    Peters W
    Lancet; 1969 Jul; 2(7610):54. PubMed ID: 4182811
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of malaria.
    Talukdar B
    Indian Pediatr; 1986 May; 23(5):371-5. PubMed ID: 3527970
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax].
    Lapierre J; Coquelin B; Galal AA; Dupouy-Camet J; Faurant C; Tourte-Schaefer C; Ancelle T; Heyer F
    Med Trop (Mars); 1984; 44(4):339-49. PubMed ID: 6394948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of CI-564, A 1:1 mixture of cycloguanil pamoate (CI-501) and 4,4'-diacetylaminodiphenylsulfone (CI-556), against multiresistant falciparum malarias.
    Chin W; Contacos PG; Coatney GR; Jeter MH; Alpert E
    Am J Trop Med Hyg; 1967 Sep; 16(5):580-4. PubMed ID: 4861322
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urgent problems of the treatment and pharmacologic prevention of malaria].
    Kotłowski A
    Wiad Parazytol; 1988; 34(4-6):503-7. PubMed ID: 3071914
    [No Abstract]   [Full Text] [Related]  

  • 10. Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.
    Schmidt LH; Rossan RN
    Antimicrob Agents Chemother; 1984 Nov; 26(5):611-42. PubMed ID: 6393864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Search for new antimalarial compounds (a review of patents)].
    Drabkina AA; Baĭbikova TA; Nikolaevskiĭ GP; Soprunov FF
    Med Parazitol (Mosk); 1981; 50(4):80-6. PubMed ID: 7024774
    [No Abstract]   [Full Text] [Related]  

  • 12. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of malaria in the 19th and 20th centuries].
    Molfese A
    Clin Ter; 1999; 150(1):81-5. PubMed ID: 10367548
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to cycloguanil pamoate (CI-501) by falciparum malaria in West Pakistan.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1965 Nov; 14(6):925-6. PubMed ID: 5320456
    [No Abstract]   [Full Text] [Related]  

  • 16. Malaria.
    Ellis CJ
    Br J Hosp Med; 1981 Oct; 26(4):400, 402-3. PubMed ID: 7030441
    [No Abstract]   [Full Text] [Related]  

  • 17. Some pharmacological aspects of antimalarial drugs.
    Botha D
    S Afr Med J; 1974 Jun; 48(29):1263-5. PubMed ID: 4607434
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of malaria.
    Choudhury DS
    Indian J Pediatr; 1985; 52(416):275-80. PubMed ID: 3910576
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug resistance in malaria.
    White NJ
    Br Med Bull; 1998; 54(3):703-15. PubMed ID: 10326295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assay of antimalarials: technologies, applications, and prospects.
    Childs GE; Webster HK
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):515-23. PubMed ID: 3554542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.